Hjem › Pladecellekræft i hoved og hals › Michigan › Lansing
Pladecellekræft i hoved og hals kliniske forsøg i Lansing, MI
4 studier for Pladecellekræft i hoved og hals søger deltagere på steder i og omkring Lansing (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- University of Michigan Health - Sparrow Lansing, Lansing
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- University of Michigan Health - Sparrow Lansing, Lansing
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
- Karmanos Cancer Institute at McLaren Greater Lansing, Lansing
Pladecellekræft i hoved og hals forsøg i andre byer
- Houston, TX47 studier
- Los Angeles, CA42 studier
- Boston, MA40 studier
- Nashville, TN39 studier
- New York City, NY39 studier
- St. Louis, MO28 studier
- Arlington, VA26 studier
- Philadelphia, PA26 studier
- Chicago, IL26 studier
- Atlanta, GA24 studier
- Pittsburgh, PA22 studier
- New Haven, CT22 studier
Andre studier i Lansing
- Lungecancer11 studier
- Prostatakræft10 studier
- Brystkræft10 studier
- Ikke-småcellet lungecancer9 studier
- Kræft (alle typer)6 studier
- Larynxcancer5 studier
- Blærecancer5 studier
- Forstyrrelser med overdreven søvnighed5 studier
- Colorektal kræft4 studier
- Nyrekancer (renocellulært karcinom)4 studier
- Tyktarmskræft4 studier
- Urotelial (overgangscelle) carcinom4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.